CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions

Spring, LM; Wander, SA; Zangardi, M; Bardia, A

Bardia, A (reprint author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Lawrence House 304,10 North Grove St, Boston, MA 02114 USA.

CURRENT ONCOLOGY REPORTS, 2019; 21 (3):

Abstract

Purpose of ReviewTo describe the clinical role of CDK 4/6 inhibitors in hormone receptor-positive (HR+) metastatic breast cancer (HR+ MBC) as well as ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索